539206 — Genomic Valley Biotech Share Price
0.000.00%
Last trade - 00:00- IN₹189.38m
- IN₹185.20m
- IN₹1.65m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.96 | ||
| Price to Tang. Book | 4.96 | ||
| Price to Free Cashflow | 47.55 | ||
| Price to Sales | 32.63 | ||
| EV to EBITDA | 50.32 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.59% | ||
| Return on Equity | 10.11% | ||
| Operating Margin | 63.1% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 8.47 | 2.08 | 0.71 | 27.23 | 1.65 | n/a | n/a | -30.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +23.01 | n/a | n/a | n/a | -98.34 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Genomic Valley Biotech Limited is an India-based company, which is engaged in the business of consultancy, and trading in agricultural and horticultural products. The Company is providing consultancy on high-tech cultivation through environment-controlled poly houses, NFT & DFT and others, and organic farming - open field cultivation using bio-fertilizer. It is involved in commercial greenhouse cultivation of crops like seed less cucumber, capsicum and others. It is involved in commercial floriculture activities with flowers like Gerbera, Chrysanthemum and others. It extends turnkey support to farmers and entrepreneurs in setting up of greenhouses and polyhouses. It is acting as authorized dealer of Netafim Irrigations India Pvt Ltd, an Israeli company specialized in marketing and selling of its irrigation related products. It is involved in the manufacturing and marketing of bio-fertilizer commercially to promote organic farming. It has a commercial plant tissue culture laboratory.
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 15th, 1996
- Public Since
- July 10th, 2015
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 3,054,500
- Address
- 4 K.M. Stone, Berry Charra Road,, BAHADURGARH, 124507
- Web
- https://www.genomicvalley.com/
- Phone
- +91 9811341542
- Auditors
- ANDROS & CO.
Upcoming Events for 539206
Q1 2026 Genomic Valley Biotech Ltd Earnings Release
Q2 2026 Genomic Valley Biotech Ltd Earnings Release
Similar to 539206
ABHISHEK FINLEASE
Bombay Stock Exchange
Adtech Systems
Bombay Stock Exchange
Alka Securities
Bombay Stock Exchange
Alkosign
Bombay Stock Exchange
All Metal Process Industries Pvt
Bombay Stock Exchange
FAQ
What is the Genomic Valley Biotech share price?
As of Today at 20:48 UTC, shares in Genomic Valley Biotech are trading at IN₹62.00. This share price information is delayed by 15 minutes.
How has the Genomic Valley Biotech share price performed this year?
Shares in Genomic Valley Biotech last closed at IN₹62.00 and the price had moved by +111.32% over the past 365 days. In terms of relative price strength the Genomic Valley Biotech share price has outperformed the S&P BSE 100 Index by +99.06% over the past year.
What are the analyst and broker recommendations for Genomic Valley Biotech?
There is no consensus recommendation for this security.
Find out moreWhat is the Genomic Valley Biotech dividend yield?
Genomic Valley Biotech does not currently pay a dividend.
Does Genomic Valley Biotech pay a dividend?
Genomic Valley Biotech does not currently pay a dividend.
When does Genomic Valley Biotech next pay dividends?
Genomic Valley Biotech does not currently pay a dividend.
How do I buy Genomic Valley Biotech shares?
To buy shares in Genomic Valley Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Genomic Valley Biotech?
As of the previous close price of IN₹62.00, shares in Genomic Valley Biotech had a market capitalisation of IN₹189.38m.
Where are Genomic Valley Biotech shares listed?
Here are the trading details for Genomic Valley Biotech:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 539206
What kind of share is Genomic Valley Biotech?
Based on an overall assessment of its quality, value and momentum Genomic Valley Biotech is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Genomic Valley Biotech share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Genomic Valley Biotech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genomic Valley Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -35.7%.
As of the last closing price of IN₹62.00, shares in Genomic Valley Biotech were trading -13.21% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Genomic Valley Biotech PE Ratio?
The Genomic Valley Biotech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹62.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Genomic Valley Biotech?
We do not have data on Genomic Valley Biotech's directors